Author

J. p. Zhang

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Ecology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1 Organism:rat· 1

Frequent Co-Authors

A. Cusumano· 1 shared B. Beers· 1 shared B. Yuan· 1 shared C. A. Fernandez· 1 shared C. Capko· 1 shared D. Symmes· 1 shared E. Guerra-Grenier· 1 shared E. Punschke· 1 shared

Activity by Year

2021-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperEcology

A. Cusumano

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Protective geometry and reproductive anatomy as candidate determinants of clutch size variation in pentatomid bugs

P. K. Abram, E. Guerra-Grenier, J. Brodeur, C. Capko, M. F. S. Aquino, B. Beers, M. C. Blassioli-Moraes, M. Borges, M. F. Cingolani, A. Cusumano, P. DeClercq, C. A. Fernandez, T. D. Gariepy, T. Haye, K. Hoelmer, , I. C. W. Hardy

The paper investigates clutch size variation in pentatomid bugs, finding that reproductive anatomy, specifically ovariole number, plays a more significant role than egg mass geometry in determining clutch size uniformity.

bioRxiv · May 16, 2022Ecology

A vimentin-targeting oral compound with host-directed antiviral and anti-inflammatory actions addresses multiple features of COVID-19 and related diseases

Z. Li, J. Wu, J. Zhou, B. Yuan, J. Chen, W. Wu, L. Mo, Z. Qu, F. Zhou, Y. Dong, K. Huang, Z. Liu, T. Wang, D. Symmes, J. Gu, , Y. Xu

This paper reports the preclinical efficacy of ALD-R491, a vimentin-targeting compound, in treating COVID-19 by reducing viral entry, enhancing pathogen clearance, and suppressing overreactive immune responses.

bioRxiv · Aug 26, 2021Pharmacology & Toxicology